York Space Systems, Inc. ((YSS)) has held its Q1 earnings call. Read on for the main highlights of the call.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
York Space Systems’ latest earnings call painted a picture of a company in motion, balancing clear growth momentum with near‑term profitability pressure. Management emphasized expanding revenue, a growing backlog, and ample liquidity, while acknowledging margin compression, a swing to negative adjusted EBITDA, and supply chain delays that push some sales into the second half of the year.
Revenue Growth Ahead of Expectations
York reported first‑quarter revenue of $116.3 million, an increase of $10.1 million or 9% year over year, putting the company ahead of internal expectations. Management framed this as evidence that demand for its satellite platforms and services remains resilient despite program timing shifts.
Backlog Expansion Underpins Future Sales
Backlog climbed 18% to $642.3 million from $542.6 million at the end of 2025, giving investors greater visibility into future revenue. A major driver was a $187 million commercial contract for a constellation of more than 20 satellites, underscoring growing customer confidence.
Liquidity Provides Strategic Flexibility
The company closed the quarter with $655.7 million in cash and equivalents, plus $150 million of availability on its revolving credit facility, for total liquidity of $805.7 million. Management stressed that this balance sheet strength allows York to fund inventory builds, capacity expansion, and acquisitions without straining operations.
Major Commercial Constellation Win
York finalized a $187 million commercial contract in February for a constellation exceeding 20 satellites, signaling a breakthrough in the commercial market. While most revenue from this deal is expected in 2027, management highlighted it as a proof point for the company’s platform strategy and scalable production model.
Government Awards and IDIQ Momentum
The company secured multiple IDIQ awards tied to next‑generation national security space architectures and extended NASA’s PEX contract through 2027. Management expects these contracts to yield near‑term task orders, bolstering both revenue visibility and York’s position in defense and civil space markets.
M&A to Deepen Capabilities and Integration
York completed the acquisition of Orbion in March 2026, bringing propulsion capabilities in‑house to improve vertical integration and cost control. It also signed a definitive agreement to acquire ALL.SPACE in April, adding jam‑resistant multi‑band tactical terminals, with closing targeted for the third quarter subject to approvals.
Contribution Margin Moves Higher
Despite headline margin pressure, contribution margin improved by one percentage point to 34%, with contribution margin dollars rising to $40.1 million from $35.3 million. Management attributed the gains to higher‑margin newer programs and overall revenue growth, suggesting core unit economics are trending in the right direction.
Scaling Production and Inventory Builds
York has begun building out its first 20 satellite platforms, alongside roughly 11 existing units, in a push to reduce time‑to‑orbit by up to 75%. The company is investing in higher production capacity and targeting a significant increase in annual throughput to meet expected demand from both government and commercial customers.
Maintained Full‑Year Guidance and Growth Outlook
Management reaffirmed 2026 revenue guidance of $545 million to $595 million, with a midpoint of $570 million implying about 48% year‑over‑year growth. Executives said expected awards and task orders in the second half should support this trajectory, and noted that roughly 70% of the guide is already backed by backlog.
Gross Margin Compression Weighs on Results
Gross margin declined to 19%, down four percentage points from a year earlier, with gross profit falling to $22.2 million from $24.6 million. The company cited estimate‑at‑completion adjustments and a one‑time depreciation charge as key drivers, emphasizing that some of the pressure is non‑recurring in nature.
Adjusted EBITDA Turns Negative
Adjusted EBITDA swung to a loss of $3.6 million in the quarter, compared with a $5.5 million profit a year ago, reflecting heavier operating expenses and one‑off items. Management framed this as a temporary trade‑off as York invests in scaling, integration, and public‑company infrastructure.
Higher SG&A and R&D from Growth Investments
Selling, general and administrative expenses plus R&D climbed 35% year over year, driven by increased headcount, public‑company compliance costs, and incremental spending from acquisitions such as ATLAS and Orbion. Executives argued these expenditures are necessary to support a larger program base and future growth.
Supply Chain Delays Shift Revenue into H2
Delays in receiving certain components are expected to push part of second‑quarter revenue into the back half of 2026, and management cautioned that Q2 could be roughly flat year over year. They characterized the issue as one of timing rather than demand, with the affected revenue still expected to land within the year.
Non‑Recurring Charges Hit Reported EPS
York posted a loss per share of $1.51 for the quarter, with about $1.07 of that loss tied to two substantial non‑recurring, non‑cash IPO‑related charges. Management highlighted these items to distinguish core operating trends from accounting impacts tied to the company’s market listing.
Funding and Contract Asset Dynamics
For Tranche Two programs, York has incurred more costs than cash received, leaving it in a contract asset position with funding under 50% to date. While this introduces some cash timing exposure, management suggested it reflects the normal cadence of long‑term government programs rather than structural funding risk.
Execution Risk Around ALL.SPACE Integration
The planned ALL.SPACE acquisition remains subject to regulatory approvals, and management acknowledged that integration and close risk could delay expected synergies. Still, they view the asset as strategically critical for providing jam‑resistant multi‑band terminals, enhancing York’s value proposition in contested environments.
Guidance Anchored by Backlog and Capacity Build
Looking ahead, York reaffirmed its 2026 revenue outlook of $545 million to $595 million and noted that about 70% of that range is already in backlog. Management expects the new commercial constellation contract to contribute modestly in 2026 and more meaningfully in 2027, while inventory builds and capacity investments aim to support a faster delivery cadence despite near‑term supply chain noise.
York’s latest earnings call portrayed a company leaning into growth, leveraging a robust backlog, strong liquidity, and strategic contracts to build a larger, more integrated space business. Investors will need to navigate short‑term margin pressure and timing risks, but the long‑term thesis hinges on York converting its expanding program base and manufacturing scale into durable, profitable growth.

